Complife Group is proud to announce that from September 2025, the company becomes part of GBA Group, an international life science services company with over 3,500 employees in 13 countries and a wide range of analytical, logistical and specialist services, in complementary markets to those already addressed by Complife.
This strategic move marks a significant milestone in Complife’s growth trajectory, enabling the company to expand its service portfolio and enhance its global reach.
The partnership with GBA Group will allow Complife to further strengthen its position in its four key markets: cosmetics, nutraceuticals, medical devices, and pharmaceuticals. By leveraging GBA Group’s extensive network and resources, Complife will accelerate its innovation and provide clients with a broader range of high-quality testing and consultancy solutions.
“We are thrilled to become a part of the GBA Group”, said Massimo Valente, CEO of Complife Group. “This collaboration is a testament to our commitment to excellence and will provide us with the resources needed to better serve our clients and explore new opportunities in the global market. We expect a future of shared success and continuous innovation, in which Complife will make its know-how available in the cosmetics sector and will have the key role of developing the growth of this division at an international level, for the entire GBA group.”
Steffen Walter, CEO of GBA Group also adds: “For the GBA Group, the merger with Complife is of great strategic importance. By adding 20 new sites with experts and a broad service portfolio, the GBA Group is further expanding its position in Europe and opening up exciting opportunities for growth in the USA, Asia and Africa.”
CONTACTS
GBA GROUP
www.gba-group.com
COMPLIFE GROUP
Advertorial
